{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-010098","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.200606+00:00","generated_at":"2026-05-21T10:27:11.925010+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Indaptus Q1 2025: cash burn $5.0M; $3.9M cash; needs capital beyond Q2 2025; Decoy20 combo trial started","bullets":["Cash and equivalents $3.9M at March 31, 2025, down from $5.8M at Dec 31, 2024; Company needs additional capital beyond Q2 2025.","Net loss per share $0.32 in Q1 2025 vs $0.45 in Q1 2024; R&D expenses $2.8M (up from $1.6M) due to Phase 1 trial costs.","Initiated Phase 1b/2 combination arm of Decoy20 with BeOne's PD-1 inhibitor Tislelizumab; weekly dosing arm concluded after 32 patients.","Patents granted in China, Japan, Israel for Decoy platform; cost-reduction plan implemented to focus on combination study."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-010098","json":"https://secwatch.observer/filing/0001641172-25-010098.json","markdown":"https://secwatch.observer/filing/0001641172-25-010098.md","text":"https://secwatch.observer/filing/0001641172-25-010098.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000164117225010098/0001641172-25-010098-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000164117225010098/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T10:27:11.925010+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}